Liminatus Pharma, Inc Class A Common Stock
Price & Volume
Stats
See more52W Range | $4.08-$33.66 |
Market Cap | $145.1M |
Shares Short | 230,060 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.16 |
News
See moreYahoo Finance • 19 days ago
Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative
Yahoo Finance • 23 days ago
Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy
Yahoo Finance • 23 days ago
Get insights into the top gainers and losers of Thursday's pre-market session.
Yahoo Finance • 24 days ago
Liminatus gains amid review to consider digital assets for treasury management
About
CEO | Mr. Chris Kim J.D., L.L.M. |
Address | 6 Centerpointe Drive, La Palma, CA, United States, 90623 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
